
Keywords: AUC; Area Under the Curve; API; Active Pharmaceutical Ingredient; Cmax; Maximum blood concentration; COPD; Chronic Obstructive Pulmonary Disease; DNX; Danirixin; HPLC; High Performance Liquid Chromatography; FaSSIF; Fasted State Simulated Intestinal Fluid